Liquidia (LQDA) Capital Expenditures Growth (5y) (2025 - 2026)
Liquidia (LQDA) Capital Expenditures Growth (5y) (2025 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.58 Bn | 86.72 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.90 Bn | 32.16 Bn | 1.97 Bn |
| 3 | Zoetis | 32.33 Bn | 30.39 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.14 Bn | 20.99 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - |
| 7 | Viatris | 20.29 Bn | 18.49 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.93 Bn | 16.62 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.63 Bn | 12.21 Bn | 785.00 Mn |
| 10 | Liquidia | 7.89 Bn | 7.66 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 179.60% |
| Dec 31, 2025 | 35.02% |
| Sep 30, 2025 | 17.88% |
| Jun 30, 2025 | -304.21% |
| Mar 31, 2025 | 334.09% |